Your browser doesn't support javascript.
loading
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study.
Addeo, Alfredo; Rothschild, Sacha I; Holer, Lisa; Schneider, Martina; Waibel, Christine; Haefliger, Simon; Mark, Michael; Fernandez, Eugenio; Mach, Nicolas; Mauti, Laetitia; Jermann, Philip M; Alborelli, Ilaria; Calgua, Byron; Savic-Prince, Spasenija; Joerger, Markus; Früh, Martin.
Affiliation
  • Addeo A; Department of Medical Oncology, University Hospital Geneva, Switzerland.
  • Rothschild SI; Department of Medical Oncology, University Hospital Basel, Switzerland; SAKK Coordinating Centre, Bern, Switzerland.
  • Holer L; SAKK Coordinating Centre, Bern, Switzerland.
  • Schneider M; SAKK Coordinating Centre, Bern, Switzerland.
  • Waibel C; Department of Medical Oncology, Kantonsspital Baden, Switzerland.
  • Haefliger S; Department of Medical Oncology, Inselspital, Switzerland.
  • Mark M; Department of Medical Oncology, Kantonsspital Graubünden, Switzerland.
  • Fernandez E; Department of Medical Oncology, University Hospital Geneva, Switzerland.
  • Mach N; Department of Medical Oncology, University Hospital Geneva, Switzerland.
  • Mauti L; Department of Medical Oncology, Kantonsspital Winterthur, Switzerland; Department of Oncology and Hematology, Kantonsspital St. Gallen, Switzerland.
  • Jermann PM; Institute of Pathology, University Hospital Basel, Switzerland.
  • Alborelli I; Institute of Pathology, University Hospital Basel, Switzerland.
  • Calgua B; Institute of Pathology, University Hospital Basel, Switzerland.
  • Savic-Prince S; Institute of Pathology, University Hospital Basel, Switzerland.
  • Joerger M; Department of Oncology and Hematology, Kantonsspital St. Gallen, Switzerland. Electronic address: markus.joerger@kssg.ch.
  • Früh M; Department of Oncology and Hematology, Kantonsspital St. Gallen, Switzerland; Department of Medical Oncology, University of Berne, Switzerland.
Lung Cancer ; 172: 154-159, 2022 10.
Article in En | MEDLINE | ID: mdl-36099710

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline Limits: Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Guideline Limits: Humans Language: En Year: 2022 Type: Article